Zhuoji Guan
No. 16 Airport Road, Baiyun District
Guangzhou, 510006, China
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Formononetin, a bioactive isoflavone compound in modified nuanxinkang, alleviates cardiorenal syndrome type 4-induced mitochondrial dysfunction by targeting Hippo-YAP signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 28, 2025
Alpha-ketoglutarate protects against myocardial infarction via FTO-mediated anti-inflammatory macrophage activation.
Journal: Basic research in cardiology
Published: January 03, 2025
Atractylodinol prevents pulmonary fibrosis through inhibiting TGF-β receptor 1 recycling by stabilizing vimentin.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 05, 2023
Nuanxinkang prevents the development of myocardial infarction-induced chronic heart failure by promoting PINK1/Parkin-mediated mitophagy.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 01, 2022
Nuanxinkang protects against ischemia/reperfusion-induced heart failure through regulating IKKβ/IκBα/NF-κB-mediated macrophage polarization.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 17, 2021
Huang-Qi San ameliorates hyperlipidemia with obesity rats via activating brown adipocytes and converting white adipocytes into brown-like adipocytes.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 23, 2020
The design and synthesis of a novel compound of berberine and baicalein that inhibits the efficacy of lipid accumulation in 3T3-L1 adipocytes.
Journal: Bioorganic & medicinal chemistry
Published: June 29, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026